Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Bertuglia

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|June 1, 2022
Beyond Clinical Trials in Patients With Multiple Myeloma: A Critical Review of Real-World ResultsLuca Bertamini, Giuseppe Bertuglia, Stefania Oliva
Hematology. American Society of Hematology. Education Program|December 9, 2023
A rational approach to functional high-risk myelomaFrancesca Gay, Giuseppe Bertuglia, Roberto Mina
Hematological Oncology|June 15, 2025
Multiple Myeloma UnpackedFrancesca Gay, Edoardo Marchetti, Giuseppe Bertuglia
International Journal of Molecular Sciences|December 23, 2022
Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?Giuseppe Bertuglia, Lorenzo Cani, Alessandra Larocca, et al.
Cancers|June 22, 2023
New Strategies for the Treatment of Older Myeloma PatientsAlessandra Larocca, Lorenzo Cani, Giuseppe Bertuglia, et al.
Frontiers in Oncology|November 28, 2025
Case Report: Iatrogenic dyspnea and respiratory failure in a multiple myeloma patient treated with carfilzomibGiuseppe Bertuglia, Mattia Verardo, Matilde Scaldaferri, et al.
Frontiers in Oncology|June 26, 2026
Current positioning and future development of belantamab mafodotin and other antibody-drug conjugates to treat multiple myelomaGiuseppe Bertuglia, Alessandro Di Nicola, Francesca Gay, et al.
Haematologica|September 4, 2025
Peripheral monoclonal plasmacytosis in infective endocarditis: a tangled webGiuseppe Bertuglia, Enrico Amaducci, Davide Stella, et al.
Blood Cancer Journal|July 19, 2024
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|June 1, 2022
Beyond Clinical Trials in Patients With Multiple Myeloma: A Critical Review of Real-World ResultsLuca Bertamini, Giuseppe Bertuglia, Stefania Oliva
Hematology. American Society of Hematology. Education Program|December 9, 2023
A rational approach to functional high-risk myelomaFrancesca Gay, Giuseppe Bertuglia, Roberto Mina
Hematological Oncology|June 15, 2025
Multiple Myeloma UnpackedFrancesca Gay, Edoardo Marchetti, Giuseppe Bertuglia
International Journal of Molecular Sciences|December 23, 2022
Normalization of the Immunological Microenvironment and Sustained Minimal Residual Disease Negativity: Do We Need Both for Long-Term Control of Multiple Myeloma?Giuseppe Bertuglia, Lorenzo Cani, Alessandra Larocca, et al.
Cancers|June 22, 2023
New Strategies for the Treatment of Older Myeloma PatientsAlessandra Larocca, Lorenzo Cani, Giuseppe Bertuglia, et al.
Frontiers in Oncology|November 28, 2025
Case Report: Iatrogenic dyspnea and respiratory failure in a multiple myeloma patient treated with carfilzomibGiuseppe Bertuglia, Mattia Verardo, Matilde Scaldaferri, et al.
Frontiers in Oncology|June 26, 2026
Current positioning and future development of belantamab mafodotin and other antibody-drug conjugates to treat multiple myelomaGiuseppe Bertuglia, Alessandro Di Nicola, Francesca Gay, et al.
Haematologica|September 4, 2025
Peripheral monoclonal plasmacytosis in infective endocarditis: a tangled webGiuseppe Bertuglia, Enrico Amaducci, Davide Stella, et al.
Blood Cancer Journal|July 19, 2024
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Medrxiv : the Preprint Server for Health Sciences|December 18, 2023
Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myelomaBachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino, et al.
Pageof 2